Please login to the form below

Not currently logged in
Email:
Password:

UK government

This page shows the latest UK government news and features for those working in and with pharma, biotech and healthcare.

Healthcare sector ‘lacks awareness’ of cybersecurity threats

Healthcare sector ‘lacks awareness’ of cybersecurity threats

The UK government should also strengthen cybersecurity expertise in MHRA, using part of the budget for the UK’s cybersecurity programme, while research institutions should focus on developing methods to assure ... The UK has world-class expertise in

Latest news

  • UK government updates the Model Clinical Trials Agreement UK government updates the Model Clinical Trials Agreement

    UK government updates the Model Clinical Trials Agreement. New regulation aims to speed-up R&D. ... Ricky Verrall, head of chief scientist office of the Scottish government, said: “Delivering a single UK agreement streamlines the research environment

  • Notch Communications wins CPI account Notch Communications wins CPI account

    Marketing and PR agency Notch Communications has secured a 4-year contract with UK-based technology innovation hub the Centre for Process Innovation (CPI), part of the UK government’s network

  • UK pharma welcomes Brexit breakthrough UK pharma welcomes Brexit breakthrough

    UK pharma welcomes Brexit breakthrough. Calls for medicines regulation and supply to be a priority in talks' next stage. ... More recently the UK government this week unveiled its much anticipated ‘sector deal’for life sciences.

  • UK trumpets life sciences post-Brexit ‘sector deal’ UK trumpets life sciences post-Brexit ‘sector deal’

    UK trumpets life sciences post-Brexit ‘ sector deal’. Highlights commitments from GlaxoSmithKline, AstraZeneca and MSD. ... The UK government has secured commitments from 25 international organisations that it says will ensure the country remains a

  • MSD to create strong UK discovery centre in London MSD to create strong UK discovery centre in London

    The decision has been trumpeted by the UK government as a reassurance that multinational pharma companies may still choose to invest in the UK as a centre for R&D, despite ... It also comes on the same day that the UK government is due to publish a white

More from news
Approximately 9 fully matching, plus 303 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    Thankfully, they reflect the position of the UK Government too. In her Mansion House speech at the beginning of March 2018, Theresa May called for a comprehensive system of mutual recognition ... Paul McGrade agrees: “Pharma should continue to

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Bayer, alongside our colleagues in the industry, shares the Government’s vision to ensure the UK becomes the best place in the world to discover, develop and use innovative medicines. ... The stronger the regulatory alignment, the more attractive the

  • Pulling together Pulling together

    But alongside the UK’s exit from the European Union, the sector faces several other significant issues. ... The real world and data. One aspect of the UK that both the government and industry are keen to talk up is its health service and the

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    On 13 July the UK government put forward the European Union (Withdrawal) Bill by which the Government hopes to convert the entire body of EU law into British law. ... The UK Government would probably want to seek equivalence and mutual recognition

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    Business leaders have been clear with the UK Government that change in itself is not a barrier as long as they have adequate time to make preparations and revise their operations. ... The problem is that there’s an incoherence between the UK

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was

  • Medicines Discovery Catapult appoints CEO Medicines Discovery Catapult appoints CEO

    As chief executive, he will primarily work with the board of directors and government organisation Innovate UK to develop and implement a new five-year business plan for the drug discovery ... The Catapult will engage the UK's experienced drug discovery

  • Innovate UK appoints director for health and life sciences Innovate UK appoints director for health and life sciences

    Innovate UK appoints director for health and life sciences. Ian Campbell takes up the newly-created post. ... In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency's life sciences and health sector.

  • Dr Keith Bragman joins Alacrita Dr Keith Bragman joins Alacrita

    Gates Foundation and at the UK government's department for international development.

  • firstlight appoints Burson-Marsteller's Christian Petrovic firstlight appoints Burson-Marsteller's Christian Petrovic

    Prior to this, Price served as communications and public affairs lead at e-skills UK, working with clients and government policy makers to inform business objectives and strategy.

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • Four Communications makes further move into healthcare sector with acquisition of Packer Forbes

    Notable campaigns run by Four include UK Government PR campaigns for the Foreign &Commonwealth Office and Cyber Streetwise, integrated &digital campaigns for the Wales Millennium Centre and Agatha Christie and marketing ... BGF Ventures is the largest UK

  • Portcullis Public Affairs

    Portcullis Public Affairs. Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. ... Health specialisms include

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics